DE3019554C2 - - Google Patents

Info

Publication number
DE3019554C2
DE3019554C2 DE3019554A DE3019554A DE3019554C2 DE 3019554 C2 DE3019554 C2 DE 3019554C2 DE 3019554 A DE3019554 A DE 3019554A DE 3019554 A DE3019554 A DE 3019554A DE 3019554 C2 DE3019554 C2 DE 3019554C2
Authority
DE
Germany
Prior art keywords
virus
nucleic acid
attenuated
infectivity
live vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3019554A
Other languages
German (de)
English (en)
Other versions
DE3019554A1 (de
Inventor
Willem Dr. 3000 Hannover De Verhagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19803019554 priority Critical patent/DE3019554A1/de
Publication of DE3019554A1 publication Critical patent/DE3019554A1/de
Application granted granted Critical
Publication of DE3019554C2 publication Critical patent/DE3019554C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32361—Methods of inactivation or attenuation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19803019554 1980-05-22 1980-05-22 Gewinnung von attenuierten viren fuer lebendimpfstoffe Granted DE3019554A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19803019554 DE3019554A1 (de) 1980-05-22 1980-05-22 Gewinnung von attenuierten viren fuer lebendimpfstoffe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803019554 DE3019554A1 (de) 1980-05-22 1980-05-22 Gewinnung von attenuierten viren fuer lebendimpfstoffe

Publications (2)

Publication Number Publication Date
DE3019554A1 DE3019554A1 (de) 1981-11-26
DE3019554C2 true DE3019554C2 (enrdf_load_stackoverflow) 1988-11-17

Family

ID=6103057

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803019554 Granted DE3019554A1 (de) 1980-05-22 1980-05-22 Gewinnung von attenuierten viren fuer lebendimpfstoffe

Country Status (1)

Country Link
DE (1) DE3019554A1 (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
DE3019554A1 (de) 1981-11-26

Similar Documents

Publication Publication Date Title
DE69732407T2 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
Otsuki et al. Comparison of the susceptibility to avian infectious bronchitis virus infection of two inbred lines of white leghorn chickens
DE1617940C2 (de) Verfahren zur Gewinnung eines für die Züchtung von Viren geeigneten Zellstammes
EP0222974B1 (de) Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff
DE69216732T2 (de) Impfstoff gegen den Geflügelanämieerreger
DE1924303A1 (de) AEthylaethylenimin als Inaktivierungsmittel
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE2120929A1 (de) Impfstoff für Geflügel gegen die Mareksche Hühnerlähme und Verfahren zu seiner Herstellung
DE2425997A1 (de) Verfahren zur herstellung von abgeschwaechtem katzenfiebervakzin
DE3019554C2 (enrdf_load_stackoverflow)
DE2415353C2 (enrdf_load_stackoverflow)
DE1235505B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE3005495C2 (de) Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen
DE2328579A1 (de) Varicella-vaccine
DE908909C (de) Verfahren zur Herstellung und Verarbeitung pathogener Viren und der sie begleitenden Stoffe
DE2225548A1 (de) Intravenoes vertraegliche staupe- und hepatitisvaccine
DE1253412B (de) Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
DE1021128B (de) Verfahren zur Herstellung eines Impfstoffes gegen die Rhinotracheitis der Rinder
AT264000B (de) Verfahren zur Herstellung eines abgeschwächten, zur Immunisierung von Menschen gegen Masern geeigneten Virus
DE959048C (de) Verfahren zur Herstellung eines Impfstoffes zur aktiven Schutzimpfung gegen spinale Kinderlaehmung
DE1792356A1 (de) Staupe-Kombinationsvaccinen und Verfahren zu ihrer Herstellung
DE1076892B (de) Verfahren zur Herstellung eines Impfstoffes zur gleichzeitigen Immunisierung von Hunden oder Fuechsen gegen die Staupe und Hepatitis contagiosa canis
DE1044362B (de) Verfahren zur Entwicklung von abgeschwaechten infektioesen Hundehepatitisviren
DE3413960A1 (de) Verfahren zur gewinnung von zellkulturen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee